Correction
for
Simpson et al., Am J Psychiatry 161 (10) 1837-1847.
Am J Psychiatry 162:644, March 2005
© 2005 American Psychiatric Association
Correction
In the October 2004 issue of the Journal, an article by Simpson et al. titled "Randomized, Controlled, Double-Blind Multicenter Comparison of the Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients With Schizophrenia or Schizoaffective Disorder" (Am J Psychiatry 2004; 161:1837–1847) contained errors in Figure 2 (incorrect number of ziprasidone-treated subjects and incorrect color coding of data plots). The correct figure appears below.
View larger version (28K):
[in this window]
[in a new window]
|
Figure 2. Least Squares Mean Changes in Clinical Global Impression (CGI) Severity Scale Score in Patients With Schizophrenia or Schizoaffective Disorder in a 6-Week Trial of Ziprasidone and Olanzapine
aNo significant differences between groups (last observation carried forward) (p=0.95, 95% CI=–0.27 to 0.29).
|
This article has been cited by other articles:
|
|
|
|
 
G. M. Simpson, P. Weiden, T. Pigott, S. Murray, C. O. Siu, and S. J. Romano
Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia
Am J Psychiatry,
August 1, 2005;
162(8):
1535 - 1538.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2005
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
